Prefrontal Electrophysiologic "Noise" and Catechol-O-Methyltransferase Genotype in Schizophrenia

Biological Psychiatry

Volumn 60, Issue 6, 2006, Pages 578-584

  Winterer, Georg ^a   Egan, Michael F ^a   Kolachana, Bhaskar S ^a   Goldberg, Terry E ^a   Coppola, Richard ^a   Weinberger, Daniel R ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

COMT; dopamine; noise; P300; prefrontal; Schizophrenia

Indexed keywords

CATECHOL METHYLTRANSFERASE; DOPAMINE; METHIONINE; VALINE;

ADULT; ARTICLE; BRAIN ELECTROPHYSIOLOGY; CAUCASIAN; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE PREDISPOSITION; DOPAMINE METABOLISM; ELECTROENCEPHALOGRAM; ELECTROENCEPHALOGRAPHY; ELECTROMAGNETIC FIELD; EVENT RELATED POTENTIAL; EVOKED AUDITORY RESPONSE; FEMALE; GENETIC RISK; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; NOISE; PREDICTION; PREFRONTAL CORTEX; PRIORITY JOURNAL; RISK ASSESSMENT; SAMPLE; SCHIZOPHRENIA; SIBLING; STATISTICAL SIGNIFICANCE;

ACOUSTIC STIMULATION; ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; CATECHOL O-METHYLTRANSFERASE; CONFIDENCE INTERVALS; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; METHIONINE; MIDDLE AGED; NOISE; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PREFRONTAL CORTEX; RETROSPECTIVE STUDIES; SCHIZOPHRENIA; SEX FACTORS; VALINE;

EID: 33748749076     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2006.03.023     Document Type: Article

References (62)

1. Abi-Dargham A., Mawalawi O., Lombardo I., Gil R., Martinez D., Huang Y., et al. Prefrontal dopamine D1 receptors and working memory in schizophrenia. J Neurosci 22 (2002) 3708-3719
2. Akil M., Kolachana B.S., Rothmond D.A., Hyde T.M., Weinberger D.R., and Kleinman J.E. Catechol-O-methyltransferase genotype and dopamine regulation in the human brain. J Neurosci 23 (2003) 2008-2013
3. Akil M., Pierri J.N., Whitehead R.E., Edgar C.L., Mohila C., Sampson A.R., and Lewis D.A. Lamina-specific alterations in the dopamine innervation of the prefrontal cortex in schizophrenic subjects. Am J Psychiatry 156 (1999) 1580-1589
4. Baudena P., Halgren E., Heit G., and Clarke J.M. Intracerebral potentials to rare target and distractor auditory and visual stimuli. III. Frontal cortex. Electroencephalogr Clin Neurophysiol 94 (1995) 251-264
5. Bearden C.E., Jawad A.F., Lynch D.R., Sokol S., Kanes S.J., McDonald-McGinn D.M., et al. Effects of a functional COMT polymorphism on prefrontal cognitive function in patients with 22q11.2 deletion syndrome. Am J Psychiatry 161 (2004) 1700-1702
6. Bertolino A., Caforio G., Blasi G., De Candia M., Latorre V., Petruzzella V., et al. Interaction of COMT (Val(108/158)Met) genotype and olanzapine treatment on prefrontal cortical function in patients with schizophrenia. Am J Psychiatry 161 (2004) 1798-1805
7. Bilder R.M., Volavka J., Czobor P., Malhotra A.K., Kennedy J.L., Ni X., et al. Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia. Biol Psychiatry 52 (2002) 701-707
8. Callicott J.H., Bertolino A., Mattay V.S., Langheim F.J., Duyn J., Coppola R., et al. Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited. Cereb Cortex 10 (2000) 1078-1092
9. Caspi A., Reichenberg A., Weiser M., Rabinowitz J., Kaplan Z., Knobler H., et al. Cognitive performance in schizophrenia patients assessed before and following the first psychotic episode. Schizophr Res 65 (2003) 87-94
10. Chen J., Lipska B.K., Halim N., Ma Q.D., Matsumoto M., Melhem S., et al. Functional analysis of genetic variation in COMT: Effects on mRNA, protein and enzyme activity in postmortem brain. Am J Hum Genet 75 (2004) 807-821
11. Diamond A., Briand L., Fossella J., and Gehlbach L. Genetic and neurochemical modulation of prefrontal functions in children. Am J Psychiatry 161 (2004) 125-132
12. Egan M.F., Goldberg T.E., Gscheidle T., Weirich M., Bigelow L.B., and Weinberger D.R. Relative risk of attention deficits in siblings of patients with schizophrenia. Am J Psychiatry 157 (2000) 1309-1316
13. 108/158Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A 98 (2001) 6917-6922
14. Egan M.F., Kojima M., Callicott J.H., Goldberg T.E., Kolachana B.S., Bertolino A., et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112 (2003) 257-269
15. Egan M.F., Straub R.E., Goldberg T.E., Yakub I., Calicott J.H., Hariri A.R., et al. Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia. Proc Natl Acad Sci U S A 101 (2004) 12604-12609
16. First M.B., Spitzer R.L., Gibbon M., and Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders Research Version (SCID-1) (1996), Biometrics Research, New York
17. Fleiss J.L. Statistical Methods for Rates and Proportions. 2nd ed. (1981), John Wiley & Sons, New York
18. Foltynie T., Goldberg T.E., Lewis S.G., Blackwell A.D., Kolachana B.S., Weinberger D.R., et al. Planning ability in Parkinson′s disease is influenced by the COMT val158met polymorphism. Mov Disorder 19 (2004) 885-891
19. Gallinat J., Bajbouj M., Sander T., Schlattmann P., Ferro E.F., Goldman D., and Winterer G. Association of the G1947A COMT (Val(108/158)Met) gene polymorphism with prefrontal P300 during information processing. Biol Psychiatry 54 (2003) 40-48
20. Gallinat J., Mulert C., Bajbouj M., Rentzsch J., Senkowski D., Schunter J., et al. Frontal and temporal dysfunction of auditory stimulus processing in schizophrenia. Neuroimage 17 (2002) 110-127
21. Glatt S.J., Faraone S.V., and Tsuang M.T. Association between a functional catechol-O-methyltransferase gene polymorphism and schizophrenia: meta-analysis of case-control and family-based studies. Am J Psychiatry 160 (2003) 469-476
22. Gogos J.A., Morgan M., Luine V., Santha M., Ogawa S., Pfaff D., and Karayiorgou M. Catechol-O-methyltransferase-deficient mice exhibit sexually dimorhic changes in catecholamine levels and behavior. Proc Natl Acad Sci U S A 95 (1998) 9991-9996
23. 158Met genotype in schizophrenia. Arch Gen Psychiatry 60 (2003) 889-896
24. Halgren E., Baudena P., Clarke J.M., Heit G., Liegeois C., Chauvel P., and Musolino A. Intracerebral potentials to rare target and distractor auditory and visual stimuli. I. Superior temporal plane and parietal lobe. Electroenceph Clin Neurophysiol 94 (1995) 191-220
25. Halgren E., Baudena P., Clarke J.M., Heit G., Marinkovic K., Devaux B., et al. Intracerebral potentials to rare target and distractor auditory and visual stimuli. II. Medial, lateral and posterior temporal lobe. Electroenceph Clin Neurophysiol 94 (1995) 229-250
26. Harrison P.J., and Weinberger D.R. Schizophrenia genes, gene expression, and neuropathology: On the matter of their convergence. Mol Psychiatry 10 (2005) 40-68
27. Hartwell J. EEGSYS Version 5.7 Users' Guide (1998), Friends Medical Science Research Center, Inc, Baltimore
28. Huotari M., Gogos J.A., Karayiorgou M., Koponen O., Forsberg M., Raasmaja A., et al. Brain catecholamine metabolism in catechol-O-methyltransferase (COMT)-deficient mice. Eur J Neurosci 15 (2002) 246-256
29. Hyoki K., Shigeta M., Tsuno N., Kawamuro Y., and Kinoshita T. Quantitative electro-oculography and electroencephalography of alertness. Electroenceph Clin Neurophysiol 106 (1998) 213-219
30. Jastak S., and Wilkinson G.S. Wide Range Achievement Test (1984), Jastak Associates, Wilmington, Delaware
31. Karoum F., Chrapusta S.J., and Egan M.F. 3-methoxytyramine is the major metabolite of released dopamine in the rat frontal cortex: Reassessment of the effects of antipsychotics on the dynamics of dopamine release and metabolism in the frontal cortex, nucleus accumbens, and striatum by a simple two pool model. J Neurochem 63 (1994) 972-979
32. Lachman H.M., Papolos D.F., Saito T., Yu Y.M., Szumlanski C.L., and Weinshilboum R.M. Human catechol-O-methyltransferase pharmacogenetics: Description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6 (1996) 243-250
33. Li Y.-H., Wirth T., Huotari M., Laitinen K., MacDonald E., and Mannisto P.T. No change of brain extracellular catecholamine levels after acute catechol-O-methyltransferase inhibition: A microdialysis study in anaesthetized rats. Eur J Pharm 356 (1998) 127-137
34. Lotta T., Vidgren J., Tilgmann C., Ulmanen I., Melen K., Julkunen I., and Taskinen J. Kinetics of human soluble and membrane-bound catechol-O-methyltransferase: A revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 34 (1995) 4202-4210
35. Malhotra A.K., Kestler L.J., Mazzanti C., Bates J.A., Goldberg T., and Goldman D. A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. Am J Psychiatry 159 (2002) 652-654
36. Matsumoto M., Weickert C.S., Akil M., Lipska B.K., Hyde T.M., Herman M.M., et al. Catechol-O-methyltransferase mRNA expression in human and rat brain: Evidence for a role in cortical neuronal function. Neuroscience 116 (2003) 127-137
37. Mattay V.S., Goldberg T.E., Fera F., Hariri A.R., Tessitore A., Egan M.F., et al. Catechol-O-methyltransferase val158met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci U S A 100 (2003) 6186-6191
38. Möcks J., Gasser T., and Köhler W. Basic statistical parameters of event-related potentials. J Psychophysiol 2 (1988) 61-70
39. Mulert C., Gallinat J., Schlattmann P., Dorn H., Pascual-Marqui R., Mientus S., et al. Reduced event-related current density in the anterior cingulate cortex in schizophrenia. Neuroimage 13 (2001) 589-600
40. Murphy K.C., Jones L.A., and Owen M.J. High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry 56 (1999) 940-945
41. Pulver A.E., Karayiorgou M., Wolyniec P.S., Lasseter V.K., Kasch L., Nestadt G., et al. Sequential strategy to identify a susceptibility gene for schizophrenia: Report of potential linkage on chromosome 22q12-q13.1: Part 1. Am J Med Genet 54 (1994) 36-43
42. Rosa A., Peralta V., Cuesta M.J., Zarzuela A., Serrano F., Martinez-Larrea A., and Fananas L. New evidence of association between COMT gene and prefrontal neurocognitive function in healthy individuals from sibling pairs discordant for psychosis. Am J Psychiatry 161 (2004) 1110-1112
43. Sazci A., Ergul E., Kucukali I., Kilic G., Kaya G., and Kara I. Catechol-O-methyltransferase gene Val108/158Met polymorphism, and susceptibility to schizophrenia: association is more significant in women. Brain Res Mol Brain Res 132 (2004) 51-56
44. Shifman S., Bronstein M., Sternfeld M., Pisanté-Shalom A., Lev-Lehman E., Weizman A., et al. A highly significant association between COMT haplotype and schizophrenia. Am J Hum Genet 71 (2002) 1296-1302
45. Statsoft. Statistica for Windows (1998), StatSoft, Tulsa
46. Tunbridge E.M., Bannerman D.M., Sharp T., and Harrison P.J. Catechol-o-methyltransferase inhibition improves set-shifting performance and elevates stimulated dopamine release in the rat prefrontal cortex. J Neurosci 24 (2004) 5331-5335
47. Weickert T.W., Goldberg T.E., Mishara A., Apud J.A., Kolachana B.S., Egan M.F., and Weinberger D.R. Catechol-O-methyltransferase val158met genotype predicts working memory response to antipsychotic medications. Biol Psychiatry 56 (2004) 677-682
48. Weinberger D.R., Berman K.F., and Illowsky B.P. Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. III. A new cohort and evidence for a monoaminergic mechanism. Arch Gen Psychiatry 45 (1988) 609-615
49. Weinberger D.R., Egan M.F., Bertolino A., Callicott J.H., Mattay V.S., Lipska B.K., et al. Prefrontal neurons and the genetics of schizophrenia. Biol Psychiatry 50 (2001) 825-844
50. Weinshilboum R.M., Otterness D.M., and Szumlanski C.L. Methylation pharmacogenetics: Catechol-O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase. Annu Rev Pharmacol Toxicol 39 (1999) 19-52
51. Winterer G., Adams C.M., Jones D.W., and Knutson B. Volition to action-an event-related fMRI-study. Neuroimage 17 (2002) 851-857
52. Winterer G., Coppola R., Egan M.F., Goldberg T.E., and Weinberger D.R. Functional and effective frontotemporal connectivity and genetic risk for schizophrenia. Biol Psychiatry 54 (2003) 1181-1192
53. Winterer G., Coppola R., Goldberg T.E., Egan M.F., Jones D.W., and Weinberger D.R. Prefrontal broadband noise, working memory and genetic risk for schizophrenia. Am J Psychiatry 161 (2004) 490-500
54. Winterer G., Egan M.F., Coppola R., Jones D.W., Sanchez C.E., and Weinberger D.R. P300 and genetic risk for schizophrenia. Arch Gen Psychiatry 60 (2003) 1158-1167
55. Winterer G., Egan M.F., Raedler T., Coppola R., and Weinberger D.R. Event-related potentials and genetic risk for schizophrenia. Biol Psychiatry 50 (2001) 407-417
56. Winterer G., Egan M.F., Raedler T., Hyde T., Coppola R., and Weinberger D.R. An association between reduced interhemispheric coherence in the temporal lobe and genetic risk for schizophrenia. Schizophr Res 49 (2001) 129-143
57. Winterer G., and Goldman D. Genetics of human prefrontal function. Brain Res Brain Res Rev 43 (2003) 134-163
58. Winterer G., Mulert C., Pascual-Marqui R., Dorn H., Frick K., and Herrmann W.M. P300 and LORETA: A comparison between normal subjects and schizophrenic patients. Brain Topography 13 (2001) 299-313
59. Winterer G., and Weinberger D.R. Cortical signal-to-noise ratio: Insight into the pathophysiology and genetics of schizophrenia. Clin Neurosci Res 3 (2003) 55-66
60. Winterer G., and Weinberger D.R. Genes, dopamine and cortical signal-to-noise ratio in schizophrenia. Trends Neurosci 27 (2004) 683-690
61. Winterer G., Ziller M., Dorn H., Frick K., Mulert C., Dahhan N., et al. Cortical activation, signal-to-noise ratio and stochastic resonance during information processing in man. Clin Neurophysiol 110 (1999) 1193-1203
62. Winterer G., Ziller M., Dorn H., Frick K., Mulert C., Wuebben Y., et al. Schizophrenia: Reduced signal-to-noise ratio and impaired phase-locking during information processing. Clin Neurophysiol 111 (2000) 837-849